Correlation Between Microbot Medical and DOMTAR
Specify exactly 2 symbols:
By analyzing existing cross correlation between Microbot Medical and DOMTAR P 675, you can compare the effects of market volatilities on Microbot Medical and DOMTAR and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microbot Medical with a short position of DOMTAR. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microbot Medical and DOMTAR.
Diversification Opportunities for Microbot Medical and DOMTAR
-0.17 | Correlation Coefficient |
Good diversification
The 3 months correlation between Microbot and DOMTAR is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Microbot Medical and DOMTAR P 675 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DOMTAR P 675 and Microbot Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microbot Medical are associated (or correlated) with DOMTAR. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DOMTAR P 675 has no effect on the direction of Microbot Medical i.e., Microbot Medical and DOMTAR go up and down completely randomly.
Pair Corralation between Microbot Medical and DOMTAR
Given the investment horizon of 90 days Microbot Medical is expected to generate 2.5 times less return on investment than DOMTAR. In addition to that, Microbot Medical is 1.67 times more volatile than DOMTAR P 675. It trades about 0.01 of its total potential returns per unit of risk. DOMTAR P 675 is currently generating about 0.04 per unit of volatility. If you would invest 5,758 in DOMTAR P 675 on September 3, 2024 and sell it today you would earn a total of 1,128 from holding DOMTAR P 675 or generate 19.59% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 92.31% |
| Values | Daily Returns |
Microbot Medical vs. DOMTAR P 675
Performance |
| Timeline |
| Microbot Medical |
| DOMTAR P 675 |
Microbot Medical and DOMTAR Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Microbot Medical and DOMTAR
The main advantage of trading using opposite Microbot Medical and DOMTAR positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microbot Medical position performs unexpectedly, DOMTAR can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DOMTAR will offset losses from the drop in DOMTAR's long position.| Microbot Medical vs. Intuitive Surgical | Microbot Medical vs. Innerscope Advertising Agency | Microbot Medical vs. Predictive Oncology | Microbot Medical vs. STAAR Surgical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |